Neuro advisory panel to meet
This article was originally published in The Gray Sheet
Executive Summary
FDA reschedules for Jan. 26 a meeting of its Neurological Devices Panel to discuss Neuronetics' NeuroStar TMS system as a potential treatment for major depressive disorder, according to the firm. The meeting originally was scheduled for Oct. 31, but was postponed to allow for further evaluation of data on the topic, according to CDRH (1"The Gray Sheet" Oct. 16, 2006, In Brief)...